Stage IVB Squamous Cell Carcinoma of the Oropharynx Withdrawn Phase 2 Trials for 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (DB15243)

IndicationStatusPhase
DBCOND0029855 (Stage IVB Squamous Cell Carcinoma of the Oropharynx)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02119728Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral CavityTreatment